β-Lactam pharmacokinetics during extracorporeal membrane oxygenation therapy: A case-control study

International Journal of Antimicrobial Agents

Volumn 45, Issue 3, 2015, Pages 278-282

  Donadello, Katia ^a   Antonucci, Elio ^a   Cristallini, Stefano ^a   Roberts, Jason A ^b,c   Beumier, Marjorie ^a   Scolletta, Sabino ^a   Jacobs, Frédérique ^a   Rondelet, Benoit ^a   De Backer, Daniel ^a   Vincent, Jean Louis ^a   Taccone, Fabio Silvio ^a  

^a ERASME HOSPITAL   (Belgium)

^b UNIVERSITY OF QUEENSLAND   (Australia)

^c ROYAL BRISBANE AND WOMEN'S HOSPITAL   (Australia)

Author keywords

Antibiotic; ECMO; Extracorporeal membrane oxygenation; ICU; Pharmacokinetics; Sepsis

Indexed keywords

MEROPENEM; PIPERACILLIN PLUS TAZOBACTAM; ANTIINFECTIVE AGENT; BETA LACTAM; PENICILLANIC ACID; PIPERACILLIN; PIPERACILLIN, TAZOBACTAM DRUG COMBINATION; THIENAMYCIN DERIVATIVE;

ACINETOBACTER BAUMANNII; ACUTE RESPIRATORY FAILURE; ADULT; ARTICLE; BACTERIUM ISOLATE; BODY WEIGHT; CASE CONTROL STUDY; CONTROLLED STUDY; DISEASE SEVERITY; DRUG BLOOD LEVEL; DRUG CLEARANCE; DRUG DISTRIBUTION; DRUG EFFECT; DRUG ELIMINATION; DRUG HALF LIFE; DRUG MONITORING; EXTENDED SPECTRUM BETA LACTAMASE PRODUCING ENTEROBACTERIACEAE; EXTRACORPOREAL OXYGENATION; FEMALE; HUMAN; INTENSIVE CARE UNIT; MAJOR CLINICAL STUDY; MALE; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA; ANALOGS AND DERIVATIVES; CHEMISTRY; MICROBIOLOGY; MIDDLE AGED; PSEUDOMONAS INFECTIONS; SEPSIS; SERUM; TREATMENT OUTCOME;

ADULT; ANTI-BACTERIAL AGENTS; BETA-LACTAMS; CASE-CONTROL STUDIES; EXTRACORPOREAL MEMBRANE OXYGENATION; FEMALE; HUMANS; MALE; MIDDLE AGED; PENICILLANIC ACID; PIPERACILLIN; PSEUDOMONAS INFECTIONS; SEPSIS; SERUM; THIENAMYCINS; TREATMENT OUTCOME;

EID: 84923696496     PISSN: 09248579     EISSN: 18727913     Source Type: Journal    
DOI: 10.1016/j.ijantimicag.2014.11.005     Document Type: Article

References (30)

1. J.F. Fraser, K. Shekar, S. Diab, S.R. Foley, C.I. McDonald, and M. Passmore ECMO - the clinician's view ISBT Sci Ser 7 2012 82 88
2. G.J. Peek, M. Mugford, R. Tiruvoipati, A. Wilson, E. Allen, M.M. Thalanany CESAR Trial Collaboration Efficacy and economic assessment of conventional ventilatory support versus extracorporeal membrane oxygenation for severe adult respiratory failure (CESAR): a multicentre randomised controlled trial Lancet 374 2009 1351 1363
3. A. Davies, D. Jones, M. Bailey, J. Beca, R. Bellomo, N. Blackwell Australia and New Zealand Extracorporeal Membrane Oxygenation (ANZ ECMO) Influenza Investigators Extracorporeal membrane oxygenation for 2009 influenza A (H1N1) acute respiratory distress syndrome JAMA 302 2009 1888 1895
4. M.L. Paden, S.A. Conrad, P.T. Rycus, R.R. Thiagarajan ELSO Registry Extracorporeal life support organization registry report 2012 ASAIO J 59 2013 202 210
5. F.S. Taccone, M. Hites, M. Beumier, S. Scolletta, and F. Jacobs Appropriate antibiotic dosage levels in the treatment of severe sepsis and septic shock Curr Infect Dis Rep 13 2011 406 415
6. K. Shekar, J.F. Fraser, M.T. Smith, and J.A. Roberts Pharmacokinetic changes in patients receiving extracorporeal membrane oxygenation J Crit Care 27 2012 e9 e18
7. W.A. Knaus, E.A. Draper, D.P. Wagner, and J.E. Zimmerman APACHE II: a severity of disease classification system Crit Care Med 13 1985 818 829
8. J.L. Vincent, R. Moreno, J. Takala, S. Willatts, A. De Mendonça, and H. Bruining The SOFA (Sepsis-related Organ Failure Assessment) score to describe organ dysfunction/failure. On behalf of the Working Group on Sepsis-Related Problems of the European Society of Intensive Care Medicine Intensive Care Med 22 1996 707 710
9. C. Covajes, S. Scolletta, L. Penaccini, E. Ocampos-Martinez, A. Abdelhadii, and M. Beumier Continuous infusion of vancomycin in septic patients receiving continuous renal replacement therapy Int J Antimicro Ag 41 2013 261 266
10. F. Wolff, G. Deprez, L. Seyler, F. Taccone, M. Hites, and B. Gulbis Rapid quantification of six β-lactams to optimize dosage regimens in severely septic patients Talanta 103 2013 153 160
11. L. Seyler, F. Cotton, F.S. Taccone, D. De Backer, P. Macours, and J.L. Vincent Recommended β-lactam regimens are inadequate in septic patients treated with continuous renal replacement therapy Crit Care 15 2011 R137
12. European Committee on Antimicrobial Susceptibility Testing Breakpoint tables for interpretation of MICs and zone diameters. Version 4.0 2014 European Committee on Antimicrobial Susceptibility Testing http://www.eucast.org/fileadmin/src/media/PDFs/EUCAST-files/Breakpoint-tables/Breakpoint-table-v-4.0.pdf [accessed January 2014]
13. F.S. Taccone, P.F. Laterre, T. Dugernier, H. Spapen, I. Delattre, and X. Wittebole Insufficient β-lactam concentrations in the early phase of severe sepsis and septic shock Crit Care 14 2010 R126
14. G.S. Casu, M. Hites, F. Jacobs, F. Cotton, F. Wolff, and M. Beumier Can changes in renal function predict variations in β-lactam concentrations in septic patients? Int J Antimicro Ag 42 2013 422 428
15. B. Vogelman, S. Gudmundsson, J. Leggett, J. Turnidge, S. Ebert, and W.A. Craig Correlation of antimicrobial pharmacokinetic parameters with therapeutic efficacy in an animal model J Infect Dis 158 1988 831 847
16. J.D. Knudsen, I. Odenholt, H. Erlendsdottir, M. Gottfredsson, O. Cars, and N. Frimodt-Møller Selection of resistant Streptococcus pneumoniae during penicillin treatment in vitro and in three animal models Antimicrob Agents Chemother 47 2003 2499 2506
17. J.A. Roberts, S.K. Paul, M. Akova, M. Bassetti, J.J. De Waele, G. Dimopoulos DALI Study Authors DALI: defining antibiotic levels in intensive care unit patients: are current β-lactam antibiotic doses sufficient for critically ill patients? Clin Infect Dis 58 2014 1072 1083
18. M. Hites, F.S. Taccone, F. Wolff, F. Cotton, M. Beumier, and D. De Backer Case-control study of drug monitoring of β-lactams in obese critically ill patients Antimicrob Agents Chemother 57 2013 708 715
19. A.A. Udy, C. Covajes, F.S. Taccone, F. Jacobs, J.L. Vincent, and J. Lipman Can population pharmacokinetic modelling guide vancomycin dosing during continuous renal replacement therapy in critically ill patients? Int J Antimicro Ag 41 2013 564 568
20. M.J. Ahsman, E.D. Wildschut, D. Tibboel, and R.A. Mathot Microanalysis of β-lactam antibiotics and vancomycin in plasma for pharmacokinetic studies in neonates Antimicrob Agents Chemother 53 2009 75 80
21. K. Shekar, J.A. Roberts, S. Ghassabian, D.V. Mullany, S.C. Wallis, and M.T. Smith Altered antibiotic pharmacokinetics during extracorporeal membrane oxygenation: cause for concern? J Antimicrob Chemother 68 2013 726 727
22. M.L. Buck Pharmacokinetic changes during extracorporeal membrane oxygenation: implications for drug therapy of neonates Clin Pharmacokinet 42 2003 403 417
23. H.G.L. Mulla, R.K. Firmin, and R.U. David Drug disposition during extracorporeal membrane oxygenation (ECMO) Paediatr Perinat Drug Ther 4 2001 109 120
24. V. Bhatt-Meht, and G. Annich Sedative clearance during extracorporeal membrane oxygenation Perfusion 20 2005 309 315
25. E.D. Wildschut, M.J. Ahsman, K. Allegaert, R.A. Mathot, and D. Tibboel Determinants of drug absorption in different ECMO circuits Intensive Care Med 36 2010 2109 2116
26. D.A. Rosen, K.R. Rosen, and D.L. Silvasi In vitro variability in fentanyl absorption by different membrane oxygenators J Cardiothorac Anesth 4 1990 332 335
27. H. Mulla, G. Lawson, C. von Anrep, M.D. Burke, D.U. Upton, and R.K. Firmin In vitro evaluation of sedative drug losses during extracorporeal membrane oxygenation Perfusion 15 2000 21 26
28. V. Bhatt-Mehta, C.E. Johnson, and R.E. Schumacher Gentamicin pharmacokinetics in term neonates receiving extracorporeal membrane oxygenation Pharmacotherapy 12 1992 28 32
29. J. Alcorn, and P.J. McNamara Pharmacokinetics in the newborn Adv Drug Delivery Rev 55 2003 667 686
30. K. Shekar, J.A. Roberts, C.I. McDonald, S. Fisquet, A.G. Barnett, and D.V. Mullany Sequestration of drugs in the circuit may lead to therapeutic failure during extracorporeal membrane oxygenation Crit Care 16 2012 R194